Guru Ownership Trend
Guru Analysis for Genmab A/S (GMAB)
Genmab A/S (GMAB), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $151.15 M.
Top institutional holders include Renaissance Technologies (RenTech) and Louis Moore Bacon.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $44.16 M net outflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 35.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2026)
Guru Consensus (Q3 2026)
FAQs for Genmab A/S (GMAB)
Major holders include Renaissance Technologies (RenTech) ($81.07 M), Louis Moore Bacon ($11.55 M), Steven Cohen ($3.73 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 2.94 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $44.16 M, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited GMAB. The total reported sell value was $44.43 M.
Yes, 1 managers opened new positions in GMAB, and 1 increased their existing holdings. The total reported buy value was $271,787.07.